©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Meta-Anal. Jun 28, 2022; 10(3): 99-121
Published online Jun 28, 2022. doi: 10.13105/wjma.v10.i3.99
Published online Jun 28, 2022. doi: 10.13105/wjma.v10.i3.99
Viral hepatitis: A narrative review of hepatitis A–E
Zunirah Ahmed, Division of Gastroenterology and Hepatology, Underwood Center for Digestive Disorders, Houston Methodist Hospital, Houston, TX 77030, United States
Akshay Shetty, Department of Gastroenterology and Hepatology, University of California, Los Angeles, CA 90095, United States
David W Victor, Sudha Kodali, Department of Hepatology, J C Walter Jr Transplant Center, Sherrie and Alan Conover Center for Liver Disease and Transplantation, Weill Cornell Medical College, Houston, TX 77030, United States
Author contributions: Ahmed Z, Shetty A, and Kodali S contributed equally to this work; Ahmed Z, Shetty A, Victor DW and Kodali S designed the research study; Ahmed Z Kodali S performed the research; Ahmed Z, Shetty A, Victor DW and Kodali S wrote the manuscript; all authors have read and approve the final manuscript.
Conflict-of-interest statement: All the authors declare no conflict of interest.
Corresponding author: Sudha Kodali, MD, Associate Professor, Department of Hepatology, Clinical Medicine Houston Methodist Academic Institute, J C Walter Jr Transplant Center, Sherrie and Alan Conover Center for Liver Disease and Transplantation, 6445 Main St Houston, TX 77030, United States. skodali@houstonmethodist.org
Received: February 16, 2022
Peer-review started: February 16, 2022
First decision: April 13, 2022
Revised: April 27, 2022
Accepted: June 24, 2022
Article in press: June 24, 2022
Published online: June 28, 2022
Processing time: 139 Days and 5.9 Hours
Peer-review started: February 16, 2022
First decision: April 13, 2022
Revised: April 27, 2022
Accepted: June 24, 2022
Article in press: June 24, 2022
Published online: June 28, 2022
Processing time: 139 Days and 5.9 Hours
Core Tip
Core tip: Viral hepatitis is an important etiology for acute and chronic hepatic dysfunction with significant mortality and morbidity. This review aims to summarize the recent advances in the field and to focus on new novel therapeutic approaches as well as highlighting the barriers to achieving a complete cure. We also focus on preventive measures and strategies to optimize care.